[Federal Register: April 16, 2003 (Volume 68, Number 73)]
[Notices]               
[Page 18664]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16ap03-95]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice hereby given of a meeting of the 
Board of Scientific Counselors, NIDA.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), Title 5 
U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the National 
Institute on Drug Abuse, including consideration of personnel 
qualifications and performance, and the competence of individual 
investigators, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: Board of Scientific Counselors, NIDA.
    Date: May 14-15, 2003.
    Time: 9 a.m. to 12 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: Intramural Research Program, National Institute on Drug 
Abuse, Johns Hopkins Bayview Campus, Bldg. C, 2nd Floor Auditorium, 
Baltimore, MD 21224.

    Contact Person: Stephen J. Heishman, Ph.D., Research 
Psychologist, Clinical Pharmacology Branch, Intramural Research 
Program, National Institute on Drug Abuse, National Institutes of 
Health, DHHS, 5500 Nathan Shock Drive, Baltimore, MD 21224, (410) 
550-1547.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS)


    Dated: April 9, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-9280 Filed 4-15-03; 8:45 am]

BILLING CODE 4140-01-M